Topotecan Completed Phase 1 / 2 Trials for Drug/Agent Toxicity by Tissue/Organ / Lung Cancers / Radiation Toxicity Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00287963Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
NCT00322751Concurrent Radiotherapy With Weekly Topotecan for Primary Treatment of Inoperable Localized Non-small Cell Lung Cancer
NCT00002537Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer